Literature DB >> 30315464

Measuring Glycolytic and Mitochondrial Fluxes in Endothelial Cells Using Radioactive Tracers.

Koen Veys1,2, Abdiel Alvarado-Diaz3, Katrien De Bock4.   

Abstract

Endothelial cells (ECs) form the inner lining of the vascular network. Although they can remain quiescent for years, ECs exhibit high plasticity in both physiological and pathological conditions, when they need to rapidly form new blood vessels in a process called angiogenesis. EC metabolism recently emerged as an important driver of this angiogenic switch. The use of radioactive tracer substrates to assess metabolic flux rates in ECs has been essential for the discovery that fatty acid, glucose, and glutamine metabolism critically contribute to vessel sprouting. In the future, these assays will be useful as a tool for the characterization of pathological conditions in which deregulation of EC metabolism underlies and/or precedes the disease, but also for the identification of anti-angiogenic metabolic targets. This chapter describes in detail the radioactive tracer substrate assays that have been used for the determination of EC metabolic flux in vitro.

Entities:  

Keywords:  Endothelium; Fatty acid oxidation; Glucose oxidation; Glutamine oxidation; Glycolysis; Metabolic flux rate; Radioactive tracer substrates

Mesh:

Substances:

Year:  2019        PMID: 30315464     DOI: 10.1007/978-1-4939-8769-6_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity.

Authors:  Koen Veys; Zheng Fan; Moheb Ghobrial; Ann Bouché; Melissa García-Caballero; Kim Vriens; Nadine Vasconcelos Conchinha; Aline Seuwen; Felix Schlegel; Tatiane Gorski; Melissa Crabbé; Paola Gilardoni; Raphaela Ardicoglu; Johanna Schaffenrath; Cindy Casteels; Gino De Smet; Ilse Smolders; Koen Van Laere; E Dale Abel; Sarah-Maria Fendt; Aileen Schroeter; Joanna Kalucka; Anna Rita Cantelmo; Thomas Wälchli; Annika Keller; Peter Carmeliet; Katrien De Bock
Journal:  Circ Res       Date:  2020-05-14       Impact factor: 17.367

2.  Roux-en-Y gastric bypass surgery reprograms enterocyte triglyceride metabolism and postprandial secretion in rats.

Authors:  Sharon Kaufman; Myrtha Arnold; Abdiel Alvarado Diaz; Heike Neubauer; Susanne Wolfrum; Harald Köfeler; Wolfgang Langhans; Jean-Philippe Krieger
Journal:  Mol Metab       Date:  2019-03-13       Impact factor: 7.422

3.  Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.

Authors:  Tijs Vandoorne; Koen Veys; Wenting Guo; Adria Sicart; Katlijn Vints; Ann Swijsen; Matthieu Moisse; Guy Eelen; Natalia V Gounko; Laura Fumagalli; Raheem Fazal; Christine Germeys; Annelies Quaegebeur; Sarah-Maria Fendt; Peter Carmeliet; Catherine Verfaillie; Philip Van Damme; Bart Ghesquière; Katrien De Bock; Ludo Van Den Bosch
Journal:  Nat Commun       Date:  2019-09-12       Impact factor: 14.919

4.  Endothelial Lactate Controls Muscle Regeneration from Ischemia by Inducing M2-like Macrophage Polarization.

Authors:  Jing Zhang; Jonathan Muri; Gillian Fitzgerald; Tatiane Gorski; Roberto Gianni-Barrera; Evi Masschelein; Gommaar D'Hulst; Paola Gilardoni; Guillermo Turiel; Zheng Fan; TongTong Wang; Mélanie Planque; Peter Carmeliet; Luc Pellerin; Christian Wolfrum; Sarah-Maria Fendt; Andrea Banfi; Christian Stockmann; Inés Soro-Arnáiz; Manfred Kopf; Katrien De Bock
Journal:  Cell Metab       Date:  2020-06-02       Impact factor: 27.287

Review 5.  Existing and Emerging Metabolomic Tools for ALS Research.

Authors:  Christine Germeys; Tijs Vandoorne; Valérie Bercier; Ludo Van Den Bosch
Journal:  Genes (Basel)       Date:  2019-12-05       Impact factor: 4.096

6.  Mitochondrial proteomics alterations in rat hearts following ischemia/reperfusion and diazoxide post‑conditioning.

Authors:  Yunchao Pan; Yuan Wang; Wenyan Shi; Yun Liu; Song Cao; Tian Yu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

Review 7.  Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment.

Authors:  Xiaoping Lin; Zizheng Xiao; Tao Chen; Steven H Liang; Huiqin Guo
Journal:  Front Oncol       Date:  2020-03-06       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.